Recombinant Syntrophobacter fumaroxidans Cobalamin synthase (cobS)

Shipped with Ice Packs
In Stock

Description

Introduction to Syntrophobacter fumaroxidans and Cobalamin Synthase

Syntrophobacter fumaroxidans (recently reclassified as Syntrophobacterium fumaroxidans) is an anaerobic, gram-negative bacterium first isolated from anaerobic granular sludge . This organism is notable for its unique metabolic capabilities, particularly its ability to oxidize propionate syntrophically in co-culture with hydrogen and formate-utilizing methanogens such as Methanospirillum hungatei . This syntrophic relationship is ecologically significant in anaerobic environments, where the degradation of complex organic matter leads to methane production. S. fumaroxidans can also grow independently using sulfate or fumarate as electron acceptors, demonstrating its metabolic versatility .

Cobalamin (vitamin B12) is an essential cofactor required for several metabolic processes across all domains of life. Its biosynthesis is remarkably complex, involving approximately 30 enzymatic steps, making it one of the most intricate small molecules produced in nature. The cobalamin synthase enzyme (CobS) plays a crucial role in the late stages of this biosynthetic pathway, specifically in the assembly of the nucleotide loop of adenosylcobalamin.

In S. fumaroxidans, the cobS gene (locus name Sfum_2609) encodes the Cobalamin synthase enzyme . Comparative genomic analyses suggest that the cobalamin biosynthesis pathway in S. fumaroxidans shares similarities with those in other anaerobic bacteria but may also exhibit unique characteristics that reflect adaptations to its syntrophic lifestyle and ecological niche.

Genetic Organization

The cobS gene in Syntrophobacter fumaroxidans is identified by the locus name Sfum_2609 . As with other bacteria, it is likely part of a larger gene cluster involved in cobalamin biosynthesis. The complete organization of this gene cluster has not been fully characterized in S. fumaroxidans, but comparative genomics suggests that the cobS gene is clustered with other genes involved in the late stages of cobalamin biosynthesis, forming a functional operon.

Comparative Analysis of Cobalamin Synthase Across Species

Table 1 presents a comparative analysis of key characteristics of Cobalamin synthase from Syntrophobacter fumaroxidans and other bacterial species.

Table 1: Comparative Characteristics of Cobalamin Synthase (CobS) from Different Bacterial Species

CharacteristicSyntrophobacter fumaroxidans CobSSalmonella typhimurium CobSPseudomonas denitrificans CobS
UniProt IDA0LLI5P0A2E6Q51910
Length (aa)248247254
Molecular Weight (kDa)~27~26.5~28
SubstratePresumed adenosylcobinamide-GDPAdenosylcobinamide-GDPAdenosylcobinamide-GDP
Cofactor RequirementsNot determinedMg2+Mg2+
Cellular LocalizationMembrane-associatedCytoplasmicCytoplasmic
PathwayAnaerobic cobalamin synthesisAnaerobic cobalamin synthesisAerobic cobalamin synthesis

Role in Cobalamin Biosynthesis

Cobalamin synthase (CobS) catalyzes a critical step in the late stages of vitamin B12 biosynthesis. Based on studies of CobS in Salmonella typhimurium, which serves as a model system for understanding cobalamin biosynthesis, the enzyme is known to catalyze the attachment of the lower ligand nucleotide to the corrin ring structure .

Specifically, S. typhimurium CobS has been demonstrated to catalyze the synthesis of adenosylcobalamin-5′-phosphate from adenosylcobinamide-GDP and α-ribazole-5′-phosphate . This reaction represents the joining of the two major structural components of the vitamin B12 molecule: the corrin ring with its attached adenosyl group (adenosylcobinamide-GDP) and the nucleotide loop (α-ribazole-5′-phosphate). By extension, it is likely that S. fumaroxidans CobS performs an analogous reaction in the vitamin B12 biosynthetic pathway of this organism.

Reaction Mechanism and Pathway Integration

In S. typhimurium, the CobS-catalyzed reaction involves the formation of a phosphodiester bond between adenosylcobinamide-GDP and α-ribazole-5′-phosphate, resulting in the elimination of GDP and the formation of adenosylcobalamin-5′-phosphate . This reaction represents a key step in the assembly of the complete cobalamin molecule.

Table 2 illustrates the position of the Cobalamin synthase reaction in the context of the late steps of cobalamin biosynthesis.

Table 2: Sequential Steps in the Late Stage of Cobalamin Biosynthesis

StepEnzymeSubstrateProductCofactors
1CobU (Adenosylcobinamide kinase/adenosylcobinamide-phosphate guanylyltransferase)Adenosylcobinamide + ATPAdenosylcobinamide-GDPMg2+
2CobT (Nicotinate-nucleotide-dimethylbenzimidazole phosphoribosyltransferase)5,6-dimethylbenzimidazole + Nicotinate mononucleotideα-ribazole-5′-phosphate-
3CobS (Cobalamin synthase)Adenosylcobinamide-GDP + α-ribazole-5′-phosphateAdenosylcobalamin-5′-phosphateMg2+
4CobC (Cobalamin-5′-phosphate phosphatase)Adenosylcobalamin-5′-phosphateAdenosylcobalamin-

Based on in vitro studies with Salmonella typhimurium enzymes, it has been demonstrated that adenosylcobinamide can be converted to adenosylcobalamin when all four enzymes (CobU, CobT, CobS, and CobC) are present in the reaction mixture . This indicates that CobS functions as part of a coordinated enzyme system for the final assembly of the cobalamin molecule.

In S. typhimurium, research has shown that adenosylcobalamin-5′-phosphate, the product of the CobS reaction, was isolated from reaction mixtures and could support the growth of a cobalamin auxotroph . This confirms the biological relevance of the intermediate produced by CobS in the vitamin B12 biosynthetic pathway.

Expression Systems and Production Methods

Recombinant Syntrophobacter fumaroxidans Cobalamin synthase has been successfully produced in heterologous expression systems, as evidenced by its commercial availability as a recombinant protein . While the specific expression system used for commercial production is not detailed in the available information, common platforms for recombinant protein expression include Escherichia coli, yeast, and insect cell systems.

The choice of expression system for recombinant CobS production would be influenced by considerations such as protein folding requirements, post-translational modifications, and the need for membrane integration or association. Given the suspected membrane association of CobS, expression systems capable of properly processing membrane proteins would be advantageous.

Recombinant production of CobS allows for several advantages in studying this enzyme. First, it enables the production of larger quantities of the protein than would be possible from native sources. Second, the addition of affinity tags facilitates purification and downstream applications. Third, recombinant systems allow for controlled expression conditions that can be optimized for protein yield and activity.

Basic Research Applications

Recombinant S. fumaroxidans CobS serves as a valuable tool for studying the mechanistic details of cobalamin biosynthesis in anaerobic bacteria. By enabling in vitro reconstitution of the cobalamin biosynthetic pathway, researchers can investigate several important aspects of this process:

  1. The specific substrates and cofactors required for CobS activity can be systematically evaluated, providing insights into the enzymatic mechanism and substrate specificity.

  2. Kinetic parameters of the CobS-catalyzed reaction can be determined under various conditions, yielding information about the efficiency and regulation of this step in vitamin B12 biosynthesis.

  3. The effects of environmental conditions (pH, temperature, redox potential) on enzyme function can be assessed, which is particularly relevant given the anaerobic lifestyle of S. fumaroxidans.

  4. Structure-function relationships can be explored through site-directed mutagenesis studies, identifying critical residues for substrate binding, catalysis, and structural integrity.

Additionally, recombinant CobS facilitates comparative studies of cobalamin biosynthesis across different bacterial species, contributing to our understanding of the evolution and diversity of this critical metabolic pathway. Such comparative studies are important for understanding how vitamin B12 biosynthesis has adapted to different ecological niches and metabolic contexts.

Biotechnological Applications and Future Perspectives

Table 4 summarizes potential biotechnological applications of recombinant Syntrophobacter fumaroxidans Cobalamin synthase and related research.

Table 4: Biotechnological Applications of Recombinant Cobalamin Synthase Research

Application AreaSpecific UsePotential Impact
Vitamin B12 ProductionEnzymatic synthesis of cobalaminEnhanced production efficiency; development of novel production routes
Synthetic BiologyEngineering of modified corrinoidsNovel compounds with altered properties for research or pharmaceutical applications
BioremediationUnderstanding syntrophic metabolismImproved anaerobic digestion processes for waste treatment
Antimicrobial DevelopmentTarget for novel antimicrobialsNew therapeutic approaches targeting vitamin B12 biosynthesis
Enzyme Evolution StudiesModel for enzyme adaptationInsights into adaptation of essential pathways in diverse environments
Structure-Based Drug DesignTemplate for inhibitor developmentRational design of specific inhibitors of bacterial metabolism

The biotechnological significance of recombinant S. fumaroxidans CobS extends to several domains with potential applications in both research and industry. Understanding the mechanisms of cobalamin biosynthesis has implications for the industrial production of vitamin B12, which is widely used in food fortification, dietary supplements, and pharmaceuticals . The ability to manipulate and engineer this pathway could lead to more efficient production methods or the synthesis of modified corrinoids with novel properties.

In the field of bioremediation, S. fumaroxidans and related syntrophic bacteria play important roles in anaerobic degradation processes relevant to wastewater treatment and biogas production . Understanding the metabolic capabilities of these organisms, including their ability to synthesize essential cofactors like cobalamin, can inform strategies for enhancing these applications. The formation of aggregates in syntrophic co-cultures of S. fumaroxidans with methanogens, as observed in recent research, highlights the complex interactions that occur in these systems and their potential relevance to biofilm formation in bioremediation contexts .

Product Specs

Form
Lyophilized powder
Note: We will prioritize shipping the format currently in stock. However, if you have specific requirements for the format, please indicate them in your order notes. We will fulfill your request whenever possible.
Lead Time
Delivery time may vary depending on the purchasing method and location. Please consult your local distributors for specific delivery timelines.
Note: All our proteins are shipped with standard blue ice packs. If you require dry ice shipping, please inform us in advance as additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. For optimal results, store working aliquots at 4°C for up to one week.
Reconstitution
We recommend centrifuging the vial briefly prior to opening to ensure the contents are settled at the bottom. Please reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%. Customers can use this as a reference.
Shelf Life
Shelf life is influenced by factors such as storage conditions, buffer ingredients, storage temperature, and the protein's inherent stability.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is necessary for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process.
Tag type is determined during production. If you have a specific tag type preference, please inform us, and we will prioritize its development.
Synonyms
cobS; Sfum_2609; Adenosylcobinamide-GDP ribazoletransferase; Cobalamin synthase; Cobalamin-5'-phosphate synthase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-248
Protein Length
full length protein
Species
Syntrophobacter fumaroxidans (strain DSM 10017 / MPOB)
Target Names
cobS
Target Protein Sequence
MWSHFGTALSFLTLFRLPFTSPRTLTPQELAESFSFFPLVGLILGFCYALPARVLSGVVP SLLLAVAITALTAVLTRALHLDGLADLADGVGGGYDPERRLEIMKDSRTGAFGALAIALA VAFKVAALDAVIRAGSFLPLLLVPVVSRLAMVLAAYRSPYARKEGGLGKPFLEHIARRHL LTALGLTAVSAFLVQPVFGLCALVLAAGTVPAFRLLCRRWLGGMTGDALGALNEIVEVLL LSAAACMY
Uniprot No.

Target Background

Function
Catalyzes the joining of adenosylcobinamide-GDP and alpha-ribazole to generate adenosylcobalamin (Ado-cobalamin). Additionally, it synthesizes adenosylcobalamin 5'-phosphate from adenosylcobinamide-GDP and alpha-ribazole 5'-phosphate.
Database Links
Protein Families
CobS family
Subcellular Location
Cell inner membrane; Multi-pass membrane protein.

Q&A

What is Syntrophobacter fumaroxidans and why is it significant in cobalamin research?

Syntrophobacter fumaroxidans is a syntrophic propionate-oxidizing bacterium first isolated from anaerobic granular sludge as strain MPOBT (DSM 10017). It represents a distinct species within the Syntrophobacter genus, demonstrating less than 26% DNA-DNA hybridization with other Syntrophobacter species . The microorganism is particularly significant in anaerobic digestion processes and nutrient cycling as it oxidizes propionate syntrophically in co-culture with hydrogen and formate-utilizing organisms such as Methanospirillum hungateii . In pure culture, S. fumaroxidans can oxidize propionate and other organic compounds using sulfate or fumarate as electron acceptors, and can also ferment fumarate independently .

The significance of S. fumaroxidans in cobalamin research stems from its ability to synthesize vitamin B12 under anaerobic conditions, making it an important model organism for studying anaerobic cobalamin biosynthesis pathways. The cobalamin synthase (cobS) enzyme from this organism is particularly valuable for understanding specialized adaptations in vitamin B12 production within anaerobic syntrophic communities.

What is the structure and basic properties of recombinant Syntrophobacter fumaroxidans Cobalamin synthase (cobS)?

Recombinant Syntrophobacter fumaroxidans Cobalamin synthase (cobS) is a protein involved in the biosynthesis of vitamin B12 (cobalamin). According to available biochemical information, the protein has the UniProt accession number A0LLI5 and is derived from Syntrophobacter fumaroxidans strain DSM 10017 / MPOB . The amino acid sequence consists of 248 amino acids (expression region 1-248) with a specific sequence beginning with "MWSHFGTALSFLTLFRLPFTSPRTLTPQELAESFSFFPLVGLILGFCYALPARVLSGVVP..." and continuing through the full protein .

The protein appears to have hydrophobic regions consistent with membrane association, as suggested by stretches of amino acids in its sequence. For research applications, the recombinant form is typically supplied in a Tris-based buffer with 50% glycerol to maintain stability . The recommended storage conditions are -20°C for regular storage and -80°C for extended preservation, with working aliquots maintained at 4°C for up to one week to avoid degradation from repeated freeze-thaw cycles .

How is Syntrophobacter fumaroxidans cobS gene organized within its genome?

While the exact genomic organization of cobS in Syntrophobacter fumaroxidans is not explicitly detailed in the provided literature, insights can be gained from studies of similar cobalamin biosynthesis operons in other anaerobic bacteria. In Salmonella typhimurium, which serves as a model organism for cobalamin biosynthesis, the cobalamin biosynthetic genes are clustered together with 25 out of 30 genes organized in one operon .

In S. typhimurium, genes involved in the Part I of the pathway (cobinamide synthesis) are designated with the prefix "cbi," while genes involved in Part III of the pathway (including cobS) are designated with the prefix "cob" . The genes are typically arranged in functional clusters that reflect the sequential steps of the biosynthetic pathway.

By analogy, we can hypothesize that the cobS gene in S. fumaroxidans is likely part of a larger operon containing other cobalamin biosynthesis genes, organized to facilitate coordinated expression under anaerobic conditions when vitamin B12 synthesis is required. The gene likely contains regulatory elements responsive to anaerobic conditions, as cobalamin synthesis in many bacteria occurs specifically under oxygen limitation.

How do researchers optimize expression systems for recombinant Syntrophobacter fumaroxidans cobS production?

Optimizing expression systems for recombinant Syntrophobacter fumaroxidans cobS production presents several specific challenges that researchers must address methodically. While the available literature doesn't detail exact protocols for S. fumaroxidans cobS expression, general principles for anaerobic bacterial enzyme expression can be applied with appropriate modifications.

First, researchers must select an appropriate expression vector and host system. E. coli is commonly used for recombinant protein production, but expressing proteins from strictly anaerobic bacteria often requires specialized strains that can properly fold proteins evolved for anaerobic environments. For membrane-associated proteins like cobS, which appears to have hydrophobic regions based on its amino acid sequence , expression systems that facilitate proper membrane insertion or inclusion body formation with subsequent refolding protocols may be necessary.

Second, optimizing growth conditions is crucial. Since the native S. fumaroxidans grows under strict anaerobic conditions, mimicking aspects of this environment during expression may improve protein folding and activity. This might include:

  • Using anaerobic expression chambers or adding reducing agents to media

  • Adjusting temperature, typically lowering to 16-20°C during induction

  • Controlling induction timing and inducer concentration

  • Supplementing with cofactors potentially required for proper folding

Third, purification strategies must be tailored to the protein's properties. Based on the storage recommendations for the commercial recombinant protein (Tris-based buffer with 50% glycerol) , researchers should consider:

  • Using stabilizing agents throughout purification

  • Maintaining reducing conditions if the protein contains sensitive thiol groups

  • Employing appropriate detergents if membrane extraction is required

  • Implementing rapid purification protocols to minimize exposure to potentially destabilizing conditions

Finally, validation of the expressed protein's functionality through activity assays is essential, as structural integrity does not guarantee catalytic activity, particularly for enzymes from strict anaerobes expressed in aerobic or facultative systems.

What experimental challenges exist in studying the interaction between cobS and other enzymes in the cobalamin biosynthetic pathway of Syntrophobacter fumaroxidans?

Studying the interactions between cobS and other enzymes in the cobalamin biosynthetic pathway of Syntrophobacter fumaroxidans presents several significant experimental challenges. As a strictly anaerobic bacterium involved in syntrophic metabolism, both in vivo and in vitro studies face particular difficulties.

The first major challenge is maintaining appropriate anaerobic conditions throughout experimental procedures. Oxygen exposure can irreversibly damage many proteins from strict anaerobes, potentially altering their structural and functional properties. Researchers must establish robust anaerobic techniques for cell growth, protein extraction, and subsequent interaction studies, which requires specialized equipment and expertise.

Second, the reconstruction of enzyme complexes and metabolic pathways presents difficulties. The cobalamin biosynthetic pathway involves numerous enzymes acting in sequence, with potentially transient interactions and intermediate channeling. Based on studies in Salmonella, where the pathway includes at least 25 genes clustered in one operon , researchers studying S. fumaroxidans must:

  • Identify all relevant biosynthetic enzymes in the pathway

  • Express and purify each component in a functional state

  • Develop assays that can detect sequential activity and protein-protein interactions

  • Account for potential membrane association of pathway components

Third, the handling of pathway intermediates presents technical challenges. Many cobalamin biosynthesis intermediates are light-sensitive, oxygen-sensitive, and challenging to synthesize as standards. Without commercial standards for these intermediates, researchers must develop strategies to generate and validate them in-house for enzyme activity assays.

Finally, the slow growth and specialized cultivation requirements of S. fumaroxidans complicate obtaining sufficient biomass for protein studies. Unlike model organisms like E. coli or Salmonella, S. fumaroxidans requires extended cultivation periods and grows only in syntrophic association or with specific electron acceptors like sulfate or fumarate , making large-scale protein production challenging.

How does cobS activity correlate with syntrophic propionate oxidation in Syntrophobacter fumaroxidans?

The correlation between cobS activity and syntrophic propionate oxidation in Syntrophobacter fumaroxidans represents an intriguing but understudied aspect of the organism's metabolism. While direct experimental evidence linking these processes is limited in the available literature, several reasonable hypotheses can be formulated based on known metabolic principles.

Syntrophic propionate oxidation by S. fumaroxidans occurs in co-culture with hydrogen and formate-utilizing organisms like Methanospirillum hungateii . This metabolic cooperation is essential because propionate oxidation becomes thermodynamically favorable only when hydrogen concentrations are kept extremely low by the syntrophic partner. Since vitamin B12 (cobalamin) serves as a cofactor for several enzymes involved in carbon metabolism, including methylmalonyl-CoA mutase (a key enzyme in propionate metabolism), a functional connection between cobS activity and propionate oxidation likely exists.

The relationship may operate through several mechanisms:

  • Cofactor requirement: Propionate oxidation via the methylmalonyl-CoA pathway requires vitamin B12 as a cofactor, making cobS activity (and thus complete cobalamin synthesis) essential for efficient propionate metabolism.

  • Regulatory coordination: The expression of cobS and other cobalamin biosynthesis genes may be coordinated with propionate oxidation pathway genes, ensuring that adequate cofactor is available when needed.

  • Energy coupling: Since vitamin B12 synthesis requires substantial energy input, its production may be regulated based on energy availability from propionate oxidation, potentially creating a feedback loop between these processes.

  • Adaptation to syntrophic conditions: The cobS enzyme in S. fumaroxidans may have evolved specific properties that optimize its function under the unique redox and energetic constraints of syntrophic growth.

An experimental approach to investigate this correlation would involve measuring cobS expression and activity levels under different growth conditions (syntrophic vs. non-syntrophic with sulfate or fumarate as electron acceptors ) and correlating these with propionate oxidation rates.

What are the optimal conditions for maintaining recombinant Syntrophobacter fumaroxidans cobS enzyme activity during laboratory experiments?

Maintaining optimal activity of recombinant Syntrophobacter fumaroxidans cobS enzyme during laboratory experiments requires careful attention to several critical parameters based on the enzyme's properties and native environment. According to available information, the following conditions should be considered:

Storage conditions:

  • Store stock preparations at -20°C for regular storage and -80°C for extended preservation

  • Maintain working aliquots at 4°C for no more than one week

  • Avoid repeated freeze-thaw cycles which can substantially reduce enzyme activity

  • Use a Tris-based buffer with 50% glycerol as recommended for the commercial preparation

Reaction conditions:

  • Maintain strict anaerobic conditions during experiments, as the native enzyme functions in a strictly anaerobic bacterium

  • Use appropriate reducing agents (such as dithiothreitol or β-mercaptoethanol) to prevent oxidative damage to potentially sensitive thiol groups

  • Consider the addition of stabilizing agents such as bovine serum albumin or specific ions that might enhance stability

pH and temperature:

  • While specific pH optima for S. fumaroxidans cobS are not detailed in the available literature, a reasonable starting point would be pH 7.0-7.5, reflecting the likely neutral to slightly alkaline intracellular environment of most bacteria

  • Temperature optimization should reflect the growth conditions of S. fumaroxidans, which is typically cultured at mesophilic temperatures (30-37°C)

Substrate considerations:

  • Ensure all substrates and cofactors are prepared anaerobically

  • For activity assays, consider that cobalamin biosynthesis involves light-sensitive intermediates, so reactions may need to be protected from light

  • If reconstituting enzyme activity from purified components, the order of addition of substrates and cofactors may be critical

Assay development:

  • Develop and validate appropriate activity assays, potentially using HPLC, mass spectrometry, or spectrophotometric methods to detect product formation

  • Include proper controls to account for potential non-enzymatic reactions or degradation of substrates under experimental conditions

By carefully controlling these parameters, researchers can maximize the likelihood of maintaining recombinant S. fumaroxidans cobS in an active state for meaningful experimental investigations.

How can researchers overcome challenges in developing specific antibodies against Syntrophobacter fumaroxidans cobS for immunolocalization studies?

Developing specific antibodies against Syntrophobacter fumaroxidans cobS for immunolocalization studies presents several unique challenges that researchers must address through strategic methodological approaches. Based on the properties of the enzyme and established immunological techniques, the following multifaceted strategy is recommended:

Antigen design and preparation:

  • Identify immunogenic epitopes within the cobS sequence that are unique to S. fumaroxidans and not conserved in related organisms. This can be accomplished through bioinformatic analysis comparing the known amino acid sequence (beginning with "MWSHFGTALSFLTLFRLPFTSPRTL...") with homologous proteins.

  • Consider developing antibodies against:

    • Synthetic peptides representing unique regions of the protein

    • Recombinant protein fragments expressed in E. coli

    • Full-length recombinant protein, taking advantage of commercially available preparations

  • For membrane-associated proteins like cobS, which appears to have hydrophobic regions, carefully extract and purify the protein using appropriate detergents while maintaining the native conformation of target epitopes.

Immunization and antibody production:

  • Select appropriate animal hosts (typically rabbits for polyclonal antibodies or mice for monoclonal antibody development)

  • Implement a strategic immunization schedule with:

    • Primary immunization using complete Freund's adjuvant

    • Multiple boost immunizations using incomplete Freund's adjuvant

    • Monitoring of antibody titers to determine optimal harvest time

  • For monoclonal antibody production, perform hybridoma screening with multiple rounds of selection to identify clones producing antibodies with optimal specificity and affinity.

Antibody purification and validation:

  • Implement rigorous validation protocols including:

    • Western blotting against recombinant cobS and whole cell extracts

    • ELISA-based quantification of antibody specificity and titer

    • Competitive binding assays to confirm specificity

    • Preabsorption controls with recombinant protein to verify specificity in immunolocalization

  • Test for cross-reactivity with homologous proteins from related organisms to ensure specificity for S. fumaroxidans cobS.

Immunolocalization optimization:

  • Develop specialized fixation protocols that preserve antigenicity while effectively permeabilizing S. fumaroxidans cells, which may have different cell wall properties compared to model organisms.

  • Optimize blocking conditions to minimize background staining, particularly important when working with anaerobic bacteria that may contain unusual membrane components.

  • Implement appropriate counterstains and controls, including pre-immune serum controls and peptide competition assays.

By systematically addressing these challenges through careful experimental design and rigorous validation, researchers can develop reliable antibodies for immunolocalization studies of cobS in S. fumaroxidans, facilitating investigations of the spatial organization of cobalamin biosynthesis within these syntrophic bacteria.

What analytical methods are most effective for measuring cobS enzyme kinetics in Syntrophobacter fumaroxidans extracts?

Measuring enzyme kinetics of cobS in Syntrophobacter fumaroxidans extracts requires sophisticated analytical approaches that address the unique challenges of working with this anaerobic bacterial enzyme. Based on the understanding of cobalamin biosynthesis and established enzymological techniques, the following analytical methods represent the most effective approaches:

Spectrophotometric assays:
Spectrophotometric methods offer real-time monitoring capabilities but must be carefully designed for cobS. While direct spectrophotometric assays for cobS activity are not well-established in the literature, potential approaches include:

  • Coupling cobS activity to changes in cofactor absorbance, such as monitoring the consumption or regeneration of ATP during the reaction

  • Following the formation of the cobalamin product, which has distinctive absorption characteristics (λmax ≈ 361 nm for adenosylcobalamin)

  • Developing coupled enzyme assays where cobS activity is linked to a reporter reaction with easily monitored spectral properties

Chromatographic methods:
High-Performance Liquid Chromatography (HPLC) coupled with appropriate detection systems offers powerful capabilities for monitoring cobS enzyme kinetics:

  • Reverse-phase HPLC can separate and quantify cobalamin pathway intermediates and products

  • The use of fluorescence detection can enhance sensitivity for detecting certain cobalamin-related compounds

  • Time-course sampling with HPLC analysis allows detailed kinetic parameter determination, though without the real-time capabilities of spectrophotometric methods

Mass spectrometry-based approaches:
Mass spectrometry provides exceptional specificity and sensitivity for analyzing cobS activity:

  • Liquid Chromatography-Mass Spectrometry (LC-MS) can definitively identify reaction products and intermediates

  • Multiple Reaction Monitoring (MRM) can target specific mass transitions for quantitative analysis of products

  • Time-course sampling with rapid quenching followed by LC-MS analysis allows detailed kinetic characterization

Radioactive tracer methods:
For challenging enzyme systems, radioactive tracers offer high sensitivity:

  • Using 14C-labeled substrates or 57Co for tracking cobalt incorporation

  • Quantifying reaction progress through scintillation counting after separation of products

  • Particularly valuable for detecting activity in complex cellular extracts or when product concentrations are very low

Experimental considerations for all methods:

ParameterRecommendationRationale
Anaerobic conditionsUse anaerobic chambers or sealed reaction vessels with oxygen scavengersPrevent oxygen inactivation of the enzyme
Temperature30-37°CMatch physiological conditions of S. fumaroxidans
pH range6.5-8.0, with detailed characterizationIdentify pH optimum within physiological range
Buffer compositionTest multiple (PIPES, HEPES, Tris)Identify optimal buffer system
Metal ionsInclude physiologically relevant ions (Mg2+, possibly Co2+)Many cobalamin synthesis enzymes require metal cofactors
Reducing agentsDTT or β-mercaptoethanolMaintain reducing environment

Researchers should initially establish proof-of-concept using the purified recombinant enzyme before progressing to more complex cellular extracts. Validation of any new assay should include controls demonstrating that measured activity depends on enzyme concentration, follows Michaelis-Menten kinetics, and can be inhibited by appropriate inhibitors or denaturation.

What insights can cross-species comparisons of cobalamin biosynthesis pathways provide for understanding the unique adaptations in Syntrophobacter fumaroxidans?

Cross-species comparisons of cobalamin biosynthesis pathways reveal significant insights into the unique adaptations present in Syntrophobacter fumaroxidans, highlighting evolutionary strategies in anaerobic metabolism. By examining the differences and similarities across diverse bacterial lineages, researchers can better understand the specialized features of S. fumaroxidans cobalamin synthesis machinery.

The anaerobic cobalamin biosynthetic pathway in bacteria typically follows either the aerobic or anaerobic route, with the latter being relevant to S. fumaroxidans. Comparative analysis reveals several key adaptations:

Enzyme specialization:
Comparative analysis reveals interesting patterns of enzyme specialization. For instance, in Salmonella, there is clear differentiation between enzymes involved in Part I (cbi-designated) and Part III (cob-designated) of the pathway . This distinction likely exists in S. fumaroxidans as well, but may show unique adaptations related to its syntrophic lifestyle where energy conservation is paramount.

Transport systems:
The presence of dedicated transport proteins (CbiN, CbiQ, and CbiO) in Salmonella suggests that cobalamin-related transport is important in many bacterial species. S. fumaroxidans may have evolved specialized transport systems for efficiently scavenging cobalamin precursors or exporting completed cobalamin, which would be particularly advantageous in the nutrient-limited syntrophic environments where it thrives .

Cobalt utilization:
The insertion and reduction of cobalt atoms is a critical step in cobalamin synthesis (reaction 10 in the pathway) . Different bacterial species have evolved various mechanisms for cobalt acquisition and incorporation. S. fumaroxidans, living in anaerobic sediments where metal availability can be variable, may have developed particularly efficient cobalt utilization systems.

Metabolic integration:
Perhaps most significantly, S. fumaroxidans shows integration between cobalamin synthesis and its core metabolic capability of syntrophic propionate oxidation . This connection is likely more pronounced than in model organisms like Salmonella, as propionate metabolism via the methylmalonyl-CoA pathway directly requires vitamin B12 as a cofactor.

The table below summarizes key comparative features:

Aspect of Cobalamin SynthesisModel Organisms (e.g., Salmonella)Likely Adaptation in S. fumaroxidans
Oxygen requirementSynthesized only under anaerobic conditions Constitutively produced in obligate anaerobe
Energy investmentSignificant but not critical constraintHighly optimized for energy conservation
Genomic organizationClustered in operons Potentially more compact organization
Metabolic integrationVarious B12-dependent pathwaysTightly coupled to propionate metabolism
RegulationResponsive to oxygen and metabolic signalsLikely responsive to syntrophic partner signals

These cross-species comparisons provide a framework for understanding how S. fumaroxidans has adapted its cobalamin synthesis machinery to support its specialized ecological niche as a syntrophic propionate oxidizer in anaerobic environments.

What are the most promising research avenues for understanding the regulatory mechanisms controlling cobS expression in Syntrophobacter fumaroxidans?

Understanding the regulatory mechanisms controlling cobS expression in Syntrophobacter fumaroxidans represents a frontier in anaerobic microbial metabolism research. Several promising research avenues could yield significant insights into how this syntrophic bacterium coordinates vitamin B12 production with its specialized metabolism.

Transcriptional regulation studies:
Investigating the transcriptional control of cobS would reveal how S. fumaroxidans modulates cobalamin synthesis in response to environmental conditions. Research approaches should include:

  • Promoter mapping and characterization using 5' RACE and reporter gene fusions

  • Identification of transcription factors through DNA-protein interaction studies

  • Comparison with known regulatory systems in other bacteria, such as the PocR regulator mentioned in Salmonella

  • Analysis of potential regulatory cross-talk between cobalamin synthesis and propionate metabolism genes

Environmental response mechanisms:
S. fumaroxidans exists in a syntrophic relationship with methanogens like Methanospirillum hungateii , suggesting its gene regulation may respond to interspecies signals. Promising research directions include:

  • Transcriptomic analysis comparing cobS expression in pure culture versus syntrophic co-culture

  • Investigation of metabolite-sensing mechanisms that might detect hydrogen or formate levels

  • Examination of potential quorum sensing or other intercellular signaling pathways

  • Study of cobS regulation in response to varying electron acceptor availability (sulfate, fumarate)

Post-transcriptional regulation:
Beyond transcriptional control, post-transcriptional mechanisms may fine-tune cobS expression. Research avenues include:

  • Identification and characterization of potential riboswitches responsive to vitamin B12 or its precursors

  • Analysis of mRNA stability and potential regulatory RNA elements

  • Investigation of translational control mechanisms specific to anaerobic bacteria

  • Proteomics analysis to detect post-translational modifications affecting CobS activity

Integration with energy metabolism:
Given the energy-limited lifestyle of syntrophic bacteria, coordination between energy status and cobalamin synthesis is likely critical. Research should focus on:

  • Correlation between cellular energy charge (ATP/ADP ratio) and cobS expression

  • Investigation of potential alarmone (like ppGpp) regulation during energy stress

  • Examination of how electron flow through different respiratory pathways affects cobS expression

  • Systems biology approaches to model the integration of cobalamin synthesis with central metabolism

Experimental approaches table:

Research QuestionMethodological ApproachExpected Outcome
What transcription factors regulate cobS?ChIP-seq, DNA affinity purificationIdentification of direct regulators
How is cobS expression affected by syntrophic partners?RNA-seq of mono- vs co-culturesDifferential expression patterns
Do riboswitches control cobS expression?mRNA structure probing, reporter assaysCharacterization of post-transcriptional control
How is cobalamin synthesis coordinated with energy metabolism?Metabolic flux analysis, quantitative proteomicsIntegrated regulatory network model

These research avenues would significantly advance understanding of how S. fumaroxidans regulates its cobalamin biosynthesis in response to its unique ecological niche and metabolic capabilities.

How might synthetic biology approaches utilizing recombinant Syntrophobacter fumaroxidans cobS contribute to biotechnological applications?

Synthetic biology approaches utilizing recombinant Syntrophobacter fumaroxidans cobS offer exciting opportunities for various biotechnological applications, leveraging this enzyme's unique properties evolved for functioning in anaerobic, energy-limited environments. Several promising directions merit exploration:

Enhanced cobalamin (vitamin B12) production systems:
The engineering of optimized vitamin B12 production platforms represents a primary application area. Strategies include:

  • Heterologous expression of S. fumaroxidans cobS in industrial production strains like Propionibacterium or Pseudomonas

  • Optimization of cobS expression through synthetic promoters and ribosome binding sites

  • Directed evolution of cobS for enhanced catalytic efficiency or stability

  • Integration of cobS into synthetic operons containing complete vitamin B12 biosynthetic pathways

Bioremediation applications:
The syntrophic lifestyle of S. fumaroxidans suggests applications in environmental biotechnology:

  • Engineering of enhanced propionate-degrading consortia for anaerobic digesters by optimizing cobalamin production

  • Development of specialized bioremediation systems for environments contaminated with propionate or related short-chain fatty acids

  • Creation of biosensors for monitoring anaerobic digestion processes through cobS-reporter gene fusions

  • Design of synthetic microbial communities with optimized syntrophic interactions for waste treatment

Biocatalysis applications:
CobS and related enzymes have potential in industrial biocatalysis:

  • Development of enzyme systems for producing specialized corrinoid compounds with industrial applications

  • Creation of immobilized enzyme systems for continuous production processes

  • Engineering of cobS variants with altered substrate specificity for novel product synthesis

  • Integration with other enzymes in multi-step catalytic systems for complex transformations

Biomedical applications:
The production of specialized cobalamin analogs has potential in biomedicine:

  • Development of diagnostic tools using modified cobalamins as molecular probes

  • Creation of drug delivery systems utilizing cobalamin uptake pathways

  • Production of therapeutic cobalamin analogs with enhanced tissue targeting

  • Design of vitamin B12-inspired antimicrobial compounds targeting bacterial metabolism

Key engineering challenges and solutions:

ChallengeEngineering SolutionPotential Impact
Low solubility of recombinant cobSFusion with solubility-enhancing tags; directed evolutionHigher yields in heterologous systems
Oxygen sensitivityCompartmentalization in synthetic organelles; protein engineering for oxidative stabilityBroader application in diverse environments
Complex substrate requirementsMetabolic engineering of precursor pathways; in vitro reconstitution systemsMore efficient production systems
Limited understanding of structure-functionStructural biology studies; computational modelingRational design of improved variants

The development of these synthetic biology applications would benefit from a multidisciplinary approach combining enzyme engineering, metabolic engineering, and systems biology. By leveraging the unique properties of S. fumaroxidans cobS, researchers could create innovative solutions for sustainable chemical production, environmental remediation, and biomedical applications.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.